SK Chemicals acquires commercialization approval of world’s 2nd zoster vaccine ‘Sky Zoster’

A Korean pharmaceutical company is expected to widen options for patients using its excellent technology power in the world’s zoster vaccine market which has been monopolized by a global pharmaceutical company.

SK Chemicals announced on the 9^th that ‘Sky Zoster Inj(project name: NBP608),’ the company’s zoster vaccine, finally acquired approval after the company developed the product with its o...